Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ILMN [NASD]
Illumina Inc.
Index- P/E112.82 EPS (ttm)1.49 Insider Own1.10% Shs Outstand139.40M Perf Week-6.71%
Market Cap23.43B Forward P/E59.44 EPS next Y2.83 Insider Trans1.05% Shs Float137.68M Perf Month0.05%
Income218.60M PEG5.39 EPS next Q0.56 Inst Own98.00% Short Float2.64% Perf Quarter-0.76%
Sales1.61B P/S14.53 EPS this Y-20.40% Inst Trans-4.96% Short Ratio3.19 Perf Half Y5.25%
Book/sh8.27 P/B20.33 EPS next Y23.33% ROA7.30% Target Price196.67 Perf Year98.82%
Cash/sh7.91 P/C21.24 EPS next 5Y20.93% ROE15.70% 52W Range72.77 - 185.00 Perf YTD52.00%
Dividend- P/FCF71.57 EPS past 5Y24.60% ROI3.90% 52W High-9.14% Beta0.71
Dividend %- Quick Ratio2.20 Sales past 5Y19.90% Gross Margin65.00% 52W Low131.00% ATR4.52
Employees3000 Current Ratio2.50 Sales Q/Q29.30% Oper. Margin19.80% RSI (14)41.16 Volatility2.80% 2.43%
OptionableYes Debt/Eq1.31 EPS Q/Q19.20% Profit Margin13.60% Rel Volume0.72 Prev Close168.10
ShortableYes LT Debt/Eq1.03 EarningsOct 20 AMC Payout0.00% Avg Volume1.14M Price168.10
Recom2.10 SMA20-4.50% SMA50-2.13% SMA20010.68% Volume0 Change0.00%
12-Aug-14Initiated Stifel Buy $200
01-Aug-14Initiated Tigress Financial Buy
24-Jul-14Reiterated Mizuho Buy $200 → $220
17-Jul-14Reiterated Maxim Group Buy $205 → $220
23-Apr-14Upgrade Maxim Group Hold → Buy $205
23-Apr-14Reiterated Mizuho Buy $175 → $200
23-Apr-14Reiterated ISI Group Neutral $152.50 → $162.50
19-Feb-14Reiterated UBS Buy $152 → $202
29-Jan-14Reiterated Mizuho Buy $150 → $175
29-Jan-14Reiterated ISI Group Neutral $134.50 → $147
17-Jan-14Reiterated Mizuho Buy $135 → $150
14-Jan-14Reiterated Mizuho Buy $125 → $135
19-Dec-13Reiterated Mizuho Buy $100 → $125
22-Oct-13Reiterated Mizuho Buy $86 → $100
22-Oct-13Reiterated Barclays Overweight $85 → $90
24-Jul-13Reiterated Mizuho Buy $83 → $86
24-Jul-13Reiterated ISI Group Neutral $75 → $78.50
23-Jul-13Reiterated UBS Buy $67 → $90
22-Jul-13Reiterated Barclays Overweight $55 → $80
23-Apr-13Reiterated UBS Buy $61 → $67
16-Sep-14 06:39AM  Dendreon (DNDN) in Focus: Stock Up 9.4% Zacks
15-Sep-14 02:37PM  IBD 50 Names Hold Gains, But Actionable Charts Scarce at Investor's Business Daily
12-Sep-14 07:11PM  IBD 50 Names Hold Gains, But Actionable Charts Scarce at Investor's Business Daily
06:20PM  Does Illumina's Latest Base Have The Profit Gene? at Investor's Business Daily
10-Sep-14 02:00PM  Myriad Genetics Posts Encouraging myPath Melanoma Data Zacks
02:33AM  On A Day When Apple Sidesteps Healthcare Technology, Mary-Claire King Shows How To Confront It at Forbes
09-Sep-14 10:00AM  Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
08-Sep-14 06:18PM  Quiet Stocks Are Typical In Market Right Now at Investor's Business Daily
10:56AM  Why Illumina (ILMN) Stock Is Gaining Today at TheStreet
06:30AM  Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions Business Wire
04-Sep-14 04:00PM  Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS Zacks
02-Sep-14 06:31AM  Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% Zacks
29-Aug-14 11:15AM  Insider Trading Alert - ILMN, ENS And RL Traded By Insiders at TheStreet
28-Aug-14 01:04PM  NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower at TheStreet
08:31AM  BioDelivery Sciences (BDSI) Jumps: Stock Moves 5.6% Higher Zacks
27-Aug-14 06:30AM  Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference Business Wire
25-Aug-14 10:36AM  Today's Momo Momentum Stock Is Illumina (ILMN) at TheStreet
21-Aug-14 06:41PM  Illumina lines up key partners Investor's Business Daily
02:30PM  Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS Zacks
12:03PM  Video: Illumina Partners With Big Pharma Firms at Investor's Business Daily
12:03PM  Illumina Forms Partnerships With Big Pharma Firms at Investor's Business Daily
07:13AM  Discovery Laboratories (DSCO) Worth Watching: Stock Up 6.9% Zacks
02:00AM  Illumina Partners With Big PharmaTo Create New Genetic Tests For Cancer at Forbes
02:00AM  Illumina Partners With Big Pharma To Create New Genetic Tests For Cancer at Forbes
02:00AM  Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology Business Wire
20-Aug-14 06:25PM  Here is the company making a killing sequencing DNA Yahoo Finance Blogs
05:31PM  Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes Benzinga
09:45AM  Flatley's Law: The Company Speeding A Genetic Revolution at Forbes
09:45AM  Flatley's Law: How One Company Is Creating Medicine's Genetic Revolution at Forbes
09:45AM  Flatley's Law: How One Company Created Medicine's Genetic Revolution at Forbes
09:16AM  Will This Analyst Upgrade Help Illumina (ILMN) Stock Today? at TheStreet
18-Aug-14 06:40AM  Achillion Pharmaceuticals (ACHN) in Focus: Stock Up 9.6% Zacks
13-Aug-14 08:11AM  Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% Zacks
12-Aug-14 04:40PM  Markets Marginally Lower In Quiet Trading Session Benzinga
07:38AM  Coverage initiated on Illumina by Stifel Briefing.com
06:52AM  Is Illumina (ILMN) a Great Growth Stock? Zacks
08-Aug-14 01:37PM  Stocks Hold Gains Midday; Walgreen Recoups Losses at Investor's Business Daily +5.20%
01:04PM  ILLUMINA INC Financials EDGAR Online Financials
10:28AM  Wall Street Transcript Interview with Scott Drake, CEO, and Guy A. Childs, CFO of The Spectranetics Corporation (SPNC) Wall Street Transcript
07-Aug-14 06:39AM  Discovery Laboratories Inc. (DSCO) in Focus: Stock Up 6% Zacks
04-Aug-14 06:39AM  Cambrex Corporation (CBM) in Focus: Stock Up 7.3% Zacks
01-Aug-14 05:02PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
01:21PM  Coverage initiated on Illumina by Tigress Financial Briefing.com
31-Jul-14 07:05PM  UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases Business Wire
07:02PM  DNA project receives £300m investment boost at Financial Times
11:55AM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:34AM  World's Richest Doctor Buys World's Most Powerful DNA Sequencer at Forbes
06:54AM  Ultragenyx Pharmaceutical (RARE) Jumps: Stock Rises 5.4% Zacks
06:30AM  Illumina Appoints Jeff Huber to its Board of Directors Business Wire
30-Jul-14 12:20PM  Qiagen Reports In-line Earnings, Beats on Revenues in Q2 Zacks
28-Jul-14 07:06AM  Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump Zacks
24-Jul-14 05:07PM  Celgene, Alexion Beat Estimates, But Biotechs Fall at Investor's Business Daily
04:26PM  Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine at Investor's Business Daily
11:58AM  Under Armour, Facebook Soar As Nasdaq Turns Positive at Investor's Business Daily
11:00AM  Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance Zacks
07:18AM  Illumina price target raised to $195 from $180 at Leerink theflyonthewall.com
23-Jul-14 05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:09PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 Business Wire
07:07AM  Q2 2014 Illumina, Inc. Earnings Release - After Market Close CCBN
22-Jul-14 09:52AM  Arks Wood Says Athena a Fall Through Cracks Stock (Audio) at Bloomberg
09:38AM  How A Giant Act Of Philanthropy May Kickstart Psychiatry at Forbes
07:45AM  Sidra to Help Qatar Grow as a Hub for Genetic Medicine Business Wire
21-Jul-14 01:33PM  Big Week of Earnings for Big Biotech ETF ETF Trends
06:30AM  Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese Regulatory Agency Business Wire
03:05AM  5 Strong Stocks To Buy Before Earnings at Seeking Alpha
17-Jul-14 08:56AM  An Unsolicited Comment On Janet Yellen's Biotech Comments at Forbes
16-Jul-14 06:31AM  Illumina acquires Myraqa at theflyonthewall.com
06:30AM  Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Business Wire
14-Jul-14 04:08PM  Illumina Names Tina S. Nova As Senior Vice Pres And General Manager Of Oncology Benzinga
04:05PM  Illumina Names Tina S. Nova as Senior Vice President and General Manager of Oncology Business Wire
03:23PM  Is NanoString The Next Illumina In Cancer Diagnostics? at Seeking Alpha
10:38AM  5 Rocket Stocks to Buy for Summer Gains at TheStreet
12-Jul-14 12:00AM  England Asks Illumina to Map 100,000 Genomes at Bloomberg
11-Jul-14 06:03PM  England Asks Illumina to Map 100,000 Genomes at Bloomberg
10-Jul-14 06:43PM  Some Stock Leaders Stay Firm Amid Pullback at Investor's Business Daily
09-Jul-14 04:05PM  ILLUMINA INC Files SEC form 8-K, Other Events EDGAR Online
06:30AM  Illumina to Announce Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 Business Wire
07-Jul-14 08:05PM  Qiagen Is Next Deal Candidate With Tax Allure: Real M&A at Bloomberg
06:16PM  Do Illumina and Incyte Belong in Your Portfolio? at Motley Fool
11:47AM  Albany Molecular's Oso Buy Seen Boosting Earnings at Investor's Business Daily
03-Jul-14 06:26PM  Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week at Investor's Business Daily
06:26PM  Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week at Investor's Business Daily
01-Jul-14 05:05PM  Illumina Expands in Europe on 3 NIPT Deals Zacks
03:23PM  Growth stocks are doing most bullish thing they can at MarketWatch
30-Jun-14 02:58PM  Stocks Mixed In Late Trade, But Growth Stocks Outperform at Investor's Business Daily
01:32PM  Nasdaq Showing Outperformance; GoPro Extends Gains at Investor's Business Daily
01:04PM  3 Stocks Pushing The Drugs Industry Higher at TheStreet
12:13PM  Midday movers: Allergan, MBIA, Treehouse Foods & More at CNBC
10:18AM  Illumina (ILMN) On Momo Momentum Watch Today at TheStreet
09:07AM  Illumina: 9 Different Insiders Have Sold Shares This Month at Seeking Alpha
03:01AM  Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, Enter Agreements with Illumina to Expand Access for Non-Invasive Prenatal Testing Across Europe Business Wire
26-Jun-14 11:14AM  Must-See Charts: 5 Large-Caps to Trade for Gains
10:06AM  Sequenom: A Reversal Of Misfortune at Seeking Alpha
10:06AM  Sequenom: A Reversal Of Misfortune
25-Jun-14 06:28AM  Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41% Zacks
06:28AM  Strength Seen in Vertex Pharmaceuticals Incorporated (VRTX) as Stock Shoots 40.41%
24-Jun-14 02:12PM  Will Danaher Corporation Bounce Back With a Big Buyout?
23-Jun-14 02:00PM  3 Hot Biotech Stocks Hitting Highs
06:32AM  Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60%
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has strategic partnerships with AstraZeneca PLC; Janssen Biotech, Inc.; and Sanofi to focus on the transition from single-analyte companion diagnostics to panel-based assays that select for companion therapeutics. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TChief Executive OfficerSep 15Sale176.495,300935,413381,262Sep 15 08:14 PM
FLATLEY JAY TChief Executive OfficerSep 11Option Exercise20.0425,000501,000406,262Sep 15 08:14 PM
FLATLEY JAY TChief Executive OfficerSep 11Sale175.9519,7003,466,126386,562Sep 15 08:14 PM
BOWMAN A BLAINEDirectorSep 09Option Exercise19.615,00098,05017,722Sep 10 09:09 PM
BOWMAN A BLAINEDirectorSep 09Sale178.085,000890,37712,722Sep 10 09:09 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Option Exercise53.1910,000531,90033,630Sep 04 06:36 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Sale180.5910,0001,805,86128,630Sep 04 06:36 PM
Ronaghi MostafaSr VP & CTOSep 02Option Exercise44.3810,000443,80038,604Sep 03 08:11 PM
BOWMAN A BLAINEDirectorSep 02Option Exercise19.615,00098,05017,722Sep 03 08:10 PM
Bouchard MichelVP, Finance & Chief AccountingSep 02Option Exercise69.3463143,75424,876Sep 03 08:10 PM
Ronaghi MostafaSr VP & CTOSep 02Sale179.6610,0001,796,58428,604Sep 03 08:11 PM
BOWMAN A BLAINEDirectorSep 02Sale179.675,000898,35612,722Sep 03 08:10 PM
Bouchard MichelVP, Finance & Chief AccountingSep 02Sale180.07686123,52824,190Sep 03 08:10 PM
FLATLEY JAY TChief Executive OfficerAug 28Option Exercise20.0430,000601,200411,262Aug 29 01:26 PM
FLATLEY JAY TChief Executive OfficerAug 28Sale178.9830,0005,369,344381,262Aug 29 01:26 PM
Dadswell CharlesSr VP & General CounselAug 27Sale180.1215127,19842,454Aug 28 02:24 PM
BOWMAN A BLAINEDirectorAug 26Option Exercise19.615,00098,05017,722Aug 26 08:19 PM
BOWMAN A BLAINEDirectorAug 26Sale179.225,000896,09112,722Aug 26 08:19 PM
BRADBURY DANIELDirectorAug 22Option Exercise36.292,10076,20914,566Aug 25 08:32 PM
BRADBURY DANIELDirectorAug 22Sale172.242,100361,70812,466Aug 25 08:32 PM
BOWMAN A BLAINEDirectorAug 19Option Exercise19.615,00098,05017,722Aug 20 08:16 PM
BOWMAN A BLAINEDirectorAug 19Sale171.705,000858,48312,722Aug 20 08:16 PM
Naclerio NicholasSr VP, Corp DevelopmentAug 15Option Exercise43.372,00086,74025,146Aug 18 07:52 PM
Naclerio NicholasSr VP, Corp DevelopmentAug 15Sale167.232,000334,46123,146Aug 18 07:52 PM
Stapley MarcSr VP & CFOAug 14Option Exercise36.301,42251,61923,533Aug 18 07:52 PM
Stapley MarcSr VP & CFOAug 14Sale166.111,422236,21122,111Aug 18 07:52 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfcrAug 13Option Exercise53.1920,0001,063,80038,630Aug 15 08:20 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfcrAug 13Sale164.6620,0003,293,20128,630Aug 15 08:20 PM
BOWMAN A BLAINEDirectorAug 12Option Exercise14.695,00073,43117,722Aug 14 08:07 PM
BOWMAN A BLAINEDirectorAug 12Sale162.964,700765,91813,022Aug 14 08:07 PM
BOWMAN A BLAINEDirectorAug 05Option Exercise14.095,00070,42517,722Aug 05 08:26 PM
BOWMAN A BLAINEDirectorAug 05Sale159.915,000799,54712,722Aug 05 08:26 PM
Bouchard MichelVP, Finance & Chief AccountingAug 01Option Exercise69.3463143,75424,821Aug 04 07:09 PM
Ronaghi MostafaSr VP & CTOAug 01Option Exercise44.3810,000443,80038,604Aug 04 07:08 PM
Bouchard MichelVP, Finance & Chief AccountingAug 01Sale160.50631101,27624,190Aug 04 07:09 PM
Ronaghi MostafaSr VP & CTOAug 01Sale159.7310,0001,597,31528,604Aug 04 07:08 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 29Option Exercise53.1910,000531,90033,519Jul 30 06:56 PM
BOWMAN A BLAINEDirectorJul 29Option Exercise14.095,00070,42517,722Jul 30 06:56 PM
BOWMAN A BLAINEDirectorJul 29Sale166.895,000834,46412,722Jul 30 06:56 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 29Sale167.4010,0001,674,03228,519Jul 30 06:56 PM
Dadswell CharlesSr VP & General CounselJul 28Sale171.0014424,62442,605Jul 29 06:09 PM
BRADBURY DANIELDirectorJul 23Option Exercise36.292,10076,20914,566Jul 24 07:43 PM
BRADBURY DANIELDirectorJul 23Sale177.872,100373,52312,466Jul 24 07:43 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Option Exercise53.1920,0001,063,80038,519Jul 16 09:28 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 15Option Exercise43.372,00086,74025,146Jul 16 09:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Sale174.0920,0003,481,76528,519Jul 16 09:28 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 15Sale174.262,000348,51123,146Jul 16 09:28 PM
Stapley MarcSr VP & CFOJul 14Option Exercise36.301,42251,61923,418Jul 15 07:32 PM
Stapley MarcSr VP & CFOJul 14Sale177.591,422252,53621,996Jul 15 07:32 PM
FLATLEY JAY TChief Executive OfficerJul 10Option Exercise20.0430,000601,200411,262Jul 11 07:09 PM
FLATLEY JAY TChief Executive OfficerJul 10Sale172.5630,0005,176,935381,262Jul 11 07:09 PM
BRADBURY DANIELDirectorJul 08Option Exercise36.292,10076,20914,566Jul 09 05:59 PM
BRADBURY DANIELDirectorJul 08Sale172.892,100363,07712,466Jul 09 05:59 PM
Bouchard MichelVP, Finance & Chief AccountingJul 01Option Exercise69.3463143,75424,821Jul 01 07:22 PM
Ronaghi MostafaSr VP & CTOJul 01Option Exercise44.3810,000443,80038,604Jul 01 07:21 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 01Option Exercise69.3425,0001,733,50048,146Jul 01 07:29 PM
Naclerio NicholasSr VP, Corp DevelopmentJul 01Sale181.4225,0004,535,57723,146Jul 01 07:29 PM
Ronaghi MostafaSr VP & CTOJul 01Sale179.4710,0001,794,70728,604Jul 01 07:21 PM
Bouchard MichelVP, Finance & Chief AccountingJul 01Sale180.08631113,62924,190Jul 01 07:22 PM
MOELLER GERALDDirectorJun 30Option Exercise42.815,000214,05022,265Jul 01 07:22 PM
MOELLER GERALDDirectorJun 30Sale178.975,000894,83017,265Jul 01 07:22 PM
RASTETTER WILLIAM HDirectorJun 30Sale174.3433458,2305,687Jul 01 07:22 PM
BRADBURY DANIELDirectorJun 27Option Exercise36.292,10076,20914,566Jun 27 07:05 PM
BRADBURY DANIELDirectorJun 27Sale171.652,100360,45512,466Jun 27 07:05 PM
Dadswell CharlesSr VP & General CounselJun 27Sale171.4419232,91642,749Jun 27 07:05 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 16Option Exercise53.1920,0001,063,80038,519Jun 17 01:46 PM
Stapley MarcSr VP & CFOJun 16Option Exercise36.301,42251,61923,418Jun 17 01:45 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 16Option Exercise43.372,00086,74025,146Jun 17 01:46 PM
Stapley MarcSr VP & CFOJun 16Sale169.251,422240,67221,996Jun 17 01:45 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 16Sale169.802,000339,60123,146Jun 17 01:46 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 16Sale169.7320,0003,394,58328,519Jun 17 01:46 PM
BRADBURY DANIELDirectorJun 12Option Exercise36.292,10076,20914,566Jun 16 03:09 PM
FLATLEY JAY TChief Executive OfficerJun 12Option Exercise20.0430,000601,200411,262Jun 16 03:09 PM
BRADBURY DANIELDirectorJun 12Sale171.172,100359,45912,466Jun 16 03:09 PM
FLATLEY JAY TChief Executive OfficerJun 12Sale172.2530,0005,167,508381,262Jun 16 03:09 PM
EASTHAM KARINDirectorJun 02Option Exercise17.586,000105,45015,826Jun 03 08:06 PM
Bouchard MichelChief Accounting OfficerJun 02Option Exercise69.3463243,82325,681Jun 03 08:05 PM
Ronaghi MostafaSr VP & CTOJun 02Option Exercise44.3810,000443,80038,604Jun 03 08:06 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 02Option Exercise43.3760,0002,602,20083,146Jun 03 08:20 PM
EASTHAM KARINDirectorJun 02Sale157.566,000945,3379,826Jun 03 08:06 PM
Bouchard MichelChief Accounting OfficerJun 02Sale155.511,491231,87024,190Jun 03 08:05 PM
Ronaghi MostafaSr VP & CTOJun 02Sale156.9310,0001,569,29228,604Jun 03 08:06 PM
Naclerio NicholasSr VP, Corp Develop & GMJun 02Sale157.6060,0009,455,93223,146Jun 03 08:20 PM
BRADBURY DANIELDirectorMay 27Option Exercise36.832,10077,34911,624May 29 06:47 PM
BRADBURY DANIELDirectorMay 27Sale159.042,100333,9879,924May 29 06:47 PM
FLATLEY JAY TChief Executive OfficerMay 22Option Exercise20.0430,000601,200411,262May 23 06:13 PM
FLATLEY JAY TChief Executive OfficerMay 22Sale154.9530,0004,648,479381,262May 23 06:13 PM
WHITFIELD ROY ADirectorMay 15Option Exercise19.614,00078,44013,196May 15 08:52 PM
Naclerio NicholasSr VP, Corp Develop & GMMay 15Option Exercise43.372,00086,74025,146May 15 08:53 PM
WHITFIELD ROY ADirectorMay 15Sale143.714,000574,8409,196May 15 08:52 PM
Naclerio NicholasSr VP, Corp Develop & GMMay 15Sale141.722,000283,44423,146May 15 08:53 PM
Stapley MarcSr VP & CFOMay 14Option Exercise36.301,42251,61923,418May 14 07:28 PM
BRADBURY DANIELDirectorMay 14Option Exercise39.142,10082,19412,024May 14 07:28 PM
Stapley MarcSr VP & CFOMay 14Sale146.941,422208,94821,996May 14 07:28 PM
BRADBURY DANIELDirectorMay 14Sale146.462,100307,5719,924May 14 07:28 PM
FLATLEY JAY TChief Executive OfficerMay 08Option Exercise20.0430,000601,200411,262May 12 08:10 PM
FLATLEY JAY TChief Executive OfficerMay 08Sale143.5930,0004,307,824381,262May 12 08:10 PM
BRADBURY DANIELDirectorMay 02Option Exercise39.142,10082,19412,024May 02 07:43 PM
BRADBURY DANIELDirectorMay 02Sale139.662,100293,2829,924May 02 07:43 PM
Ronaghi MostafaSr VP & CTOMay 01Option Exercise44.3810,000443,80038,604May 01 07:01 PM